Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma

✍ Scribed by R. E. Kast

• Book ID: 106481361
• Publisher: Springer US
• Year: 2009
• Tongue: English
• Weight: 160 KB
• Volume: 94
• Category: Article
• ISSN: 0167-594X
• DOI: 10.1007/s11060-009-9863-y